U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C9H12O3
Molecular Weight 168.1898
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 1,3,5-TRIMETHOXYBENZENE

SMILES

COC1=CC(OC)=CC(OC)=C1

InChI

InChIKey=LKUDPHPHKOZXCD-UHFFFAOYSA-N
InChI=1S/C9H12O3/c1-10-7-4-8(11-2)6-9(5-7)12-3/h4-6H,1-3H3

HIDE SMILES / InChI

Description
Curator's Comment: Description was created using several sources including: http://www.ema.europa.eu/docs/en_GB/document_library/contacts/ochassany_DI.pdf; https://www.ncbi.nlm.nih.gov/pubmed/14017697; https://www.ncbi.nlm.nih.gov/pubmed/15122041; https://www.ncbi.nlm.nih.gov/pubmed/17439513

1,3,5-trimethoxybenzene (trade name Spasfon (R), registered and marketed in France) is an antispasmodic drug acting on smooth muscle. It is indicated for symptomatic treatment of pain related to functional disorders of the gastrointestinal tract and biliary tract, urinary tract (renal colic) or gynecological pain, and to reduce early contractions during a pregnancy. It is widely prescribed in cases of intestinal disorders including infectious and other bowel disease, gastrointestinal symptoms, urinary tract and genital tract disease. Spasfon is produced as film-coated tablets and solution for injection. 1,3,5-Trimethoxybenzene is a key component of the Chinese rose odor. This compound is synthesized in three successive methylation steps from phloroglucinol, the initial precursor.

Originator

Curator's Comment: In 2002, the Laboratory Louis Lafon was taken by Cephalon (USA) that acquired the entire portfolio of Lafon products sold in France including SPASFON(R) (phloroglucinol).

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Secondary
SPASFON(R)

Approved Use

Indicated for symptomatic treatment of pain related to functional disorders of the gastrointestinal tract and biliary tract; treatment of spasm and acute pain of the urinary tract: renal colic; symptomatic treatment of painful spasm in gynaecology; adjuvant therapy for contractions during pregnancy, in combination with rest

Launch Date

1973
Palliative
SPASFON(R)

Approved Use

Indicated for symptomatic treatment of pain related to functional disorders of the gastrointestinal tract and biliary tract; treatment of spasm and acute pain of the urinary tract: renal colic; symptomatic treatment of painful spasm in gynaecology; adjuvant therapy for contractions during pregnancy, in combination with rest

Launch Date

1973
Palliative
SPASFON(R)

Approved Use

Indicated for symptomatic treatment of pain related to functional disorders of the gastrointestinal tract and biliary tract; treatment of spasm and acute pain of the urinary tract: renal colic; symptomatic treatment of painful spasm in gynaecology; adjuvant therapy for contractions during pregnancy, in combination with rest

Launch Date

1973
PubMed

PubMed

TitleDatePubMed
Metallocyclic receptors with Re(I)/Os(II)-based moieties: molecular photophysics and selective molecular sensing.
2001 Jun 1
Reactions of N-methyl-N-(4-biphenylyl)nitrenium ion with electron-rich arenes: laser flash photolysis and product studies.
2002 Apr 10
Biosynthesis of the major scent components 3,5-dimethoxytoluene and 1,3,5-trimethoxybenzene by novel rose O-methyltransferases.
2002 Jul 17
Computational insight into the reaction intermediates in the glycosylation reaction assisted by donor heteroatoms.
2003 Feb 7
Control of extremely fast competitive consecutive reactions using micromixing. Selective Friedel-Crafts aminoalkylation.
2005 Aug 24
Adsorption of single-ring organic compounds to wood charcoals prepared under different thermochemical conditions.
2005 Jun 1
Electron capture in charge-tagged peptides. Evidence for the role of excited electronic states.
2007 Dec
Solvent-free iodination of organic molecules using the I(2)/urea-H(2)O(2) reagent system.
2007 Feb 21
Bimolecular hole transfer from the trimethoxybenzene radical cation in the excited state.
2007 Jun 7
Transcriptomic and metabolite analyses of Cabernet Sauvignon grape berry development.
2007 Nov 22
Investigation of the dynamic stereochemistry of dimesityl-2,4,6-trimethoxyphenylmethane by complete lineshape analysis and 2D EXSY NMR spectroscopy.
2008 Apr
Validation of a quantitative NMR method for suspected counterfeit products exemplified on determination of benzethonium chloride in grapefruit seed extracts.
2008 Aug 5
Sila-haloperidol, a silicon analogue of the dopamine (D2) receptor antagonist haloperidol: synthesis, pharmacological properties, and metabolic fate.
2008 Jan
A carbene-carbene complex equilibrium.
2010 Aug 11
Mesit-yl(2,4,6-trimeth-oxy-phen-yl)borinic acid.
2010 Jun 18
(E)-1-(2-Fur-yl)-3-(2,4,6-trimeth-oxy-phen-yl)prop-2-en-1-one.
2010 Sep 15
Patents

Sample Use Guides

In Vitro Use Guide
Assays for halogenation by neutrophils and eosinophils from the blood of normal volunteers and patients with eosinophilia were carried out using labeled with radioactive carbon 1,3,5-trimethoxybenzene at 1 X 10(-4) M (14C = 0.5 nCi/ml). Total amount of active halogen trapped by 1,3,5-trimethoxybenzene from eosinophils increases by over 2-fold as the added bromide concentration increases from 0 to 100 microM, with approximately 40 nmol of halogen trapped per million cells at the highest bromide level.
Name Type Language
1,3,5-TRIMETHOXYBENZENE
JAN  
Systematic Name English
TRIMETHYLPHLOROGLUCINOL
WHO-DD  
Systematic Name English
Trimethylphloroglucinol [WHO-DD]
Common Name English
PHLOROGLUCINOL TRIMETHYL ETHER [INCI]
Common Name English
PHLOROGLUCINOL TRIMETHYL ETHER
INCI  
INCI  
Official Name English
1,3,5-TRIMETHOXYBENZENE [JAN]
Common Name English
NSC-90060
Code English
Code System Code Type Description
SMS_ID
100000092189
Created by admin on Fri Dec 15 18:07:33 GMT 2023 , Edited by admin on Fri Dec 15 18:07:33 GMT 2023
PRIMARY
ECHA (EC/EINECS)
210-673-4
Created by admin on Fri Dec 15 18:07:33 GMT 2023 , Edited by admin on Fri Dec 15 18:07:33 GMT 2023
PRIMARY
PUBCHEM
69301
Created by admin on Fri Dec 15 18:07:33 GMT 2023 , Edited by admin on Fri Dec 15 18:07:33 GMT 2023
PRIMARY
NSC
90060
Created by admin on Fri Dec 15 18:07:33 GMT 2023 , Edited by admin on Fri Dec 15 18:07:33 GMT 2023
PRIMARY
EVMPD
SUB15620MIG
Created by admin on Fri Dec 15 18:07:33 GMT 2023 , Edited by admin on Fri Dec 15 18:07:33 GMT 2023
PRIMARY
RXCUI
38716
Created by admin on Fri Dec 15 18:07:33 GMT 2023 , Edited by admin on Fri Dec 15 18:07:33 GMT 2023
PRIMARY RxNorm
CAS
621-23-8
Created by admin on Fri Dec 15 18:07:33 GMT 2023 , Edited by admin on Fri Dec 15 18:07:33 GMT 2023
PRIMARY
FDA UNII
00VJI3VG3D
Created by admin on Fri Dec 15 18:07:33 GMT 2023 , Edited by admin on Fri Dec 15 18:07:33 GMT 2023
PRIMARY
EVMPD
SUB49266
Created by admin on Fri Dec 15 18:07:33 GMT 2023 , Edited by admin on Fri Dec 15 18:07:33 GMT 2023
PRIMARY
CHEBI
31038
Created by admin on Fri Dec 15 18:07:33 GMT 2023 , Edited by admin on Fri Dec 15 18:07:33 GMT 2023
PRIMARY
MESH
C015560
Created by admin on Fri Dec 15 18:07:33 GMT 2023 , Edited by admin on Fri Dec 15 18:07:33 GMT 2023
PRIMARY
EPA CompTox
DTXSID0045963
Created by admin on Fri Dec 15 18:07:33 GMT 2023 , Edited by admin on Fri Dec 15 18:07:33 GMT 2023
PRIMARY